Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
PLA/PLGA Injectable Microspheres
Product Overview
Development Status:
Active Development
Target:
Female
Mode:
Hormonal
Delivery Type:
Injectable
Duration Type:
Long-acting
Description:
The Shanghai Institute of Planned Parenthood Research (SIPPR) is developing a long-acting, injectable PLA/PLGA microsphere formulation for delivery of LNG for up to 6 months.
Updated date:
May 30, 2018
Vertical Tabs
Product Details
Active Pharmaceutical Ingredient (API):
levonorgestrel
Inactive material:
PLA/PLGA
Potential Multi-Purpose Technology (MPT):
No
Regimen:
single injection
Duration:
6 months
Partner:
Shanghai Institute of Planned Parenthood Research (SIPPR)
,
FHI 360
Status
Project Phase:
Early Development
Project Stage:
Pre-clinical
Began discovery in:
2013
Status Details:
In vivo PK data in rats indicates 6-7 months release for select formulations.
Programmatic Considerations
Additional Information
Additional Information:
FHI 360 website
Download Product Report
